https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDIGO @jlgorriz @jorgericof @nuriaareste @sociedadSEEN @SENefrologia https://t.co/y809nGZdyI
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2022 – May 2025Where it's discussed
-
X / Twitter232 posts
-
News42 articles
-
Bluesky10 posts
-
YouTube2 videos
-
Facebook2 posts
-
Blogs2 articles
AI synopsis
What people are saying
Several discussions highlight key recommendations from the publication, such as the importance of holistic approaches and specific treatment algorithms for diabetes and CKD. Phrases like 'suggested approach in dosing metformin' and 'treatment algorithm for selecting glucose-lowering drugs' indicate that participants are focusing on actionable insights from the guidelines. The overall tone is informative and enthusiastic, reflecting a collective understanding of the complexities in managing diabetes within the context of CKD.
Most discussions reflect a consensus on the importance of the KDIGO guidelines, indicating moderate agreement.
The variety of topics and repeated references to specific recommendations demonstrate a strong interest in diabetes management in CKD.
While engagement is present, many discussions appear to summarize information rather than delve deeply into implications or personal experiences.
Participants perceive the guidelines as having a significant impact on the management of diabetes and CKD, particularly regarding treatment approaches.
Abstract in brief
- The guideline emphasizes the importance of early diagnosis and regular monitoring of kidney function in patients with diabetes to prevent progression of chronic kidney disease (CKD).
- It recommends individualized treatment approaches that include lifestyle modifications and specific medications that can improve both diabetes control and kidney health.
- The guidelines highlight the need for a multidisciplinary care team to effectively manage diabetes and CKD, ensuring all aspects of patient health are addressed.
Top posts
Most liked on X and BlueskyEl Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Medicina Interna. • https://t.co/eJ4rMc95Nh • https://t.co/GVFP5OJtTr • https://t.co/8rAWllWGfQ https://t.co/TqvtrjNS5M
Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int. ➡️ https://t.co/3zrkRwdq4n #DKD https://t.co/qkhaHMAT7O
Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #Nephpearls #NephJC
All mentions
Understanding Quantum Entanglement and Its Implications
This video explores the concept of quantum entanglement, discussing its fundamental principles and significant implications in quantum physics. Understand how entangled particles communicate instantaneously, regardless…
Exploring Quantum Mechanics: Fundamental Principles Explained
This video delves into the core concepts of quantum mechanics, focusing on fundamental principles that govern the behavior of matter and energy at microscopic scales. Viewers will gain insights into wave-particle…
Nun auch auf Deutsch gut geleitet: KDIGO-Leitlinie übersetzt https://www.europesays.com/de/100299/ Die KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease gibt es nun auch in…#de #deutschland
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Recommendation from @goKDIGO
RT @edgarvlermamd: Recommendation from @goKDIGO
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Recommendation from @goKDIGO
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #…
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #…
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #…
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #…
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Recommendation from @goKDIGO
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #…
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Recommendation from @goKDIGO
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
Recommendation from @goKDIGO
Recommendation from @kdigo.org
Did they check Vitamin B12 levels? #Nephpearls #NephJC #NephSky
RT @edgarvlermamd: Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
RT @edgarvlermamd: Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #…
Personally, I have no experience with using Metformin at eGFR <30; in fact, I have been discontinuing Metformin when eGFR is <30
Suggested approach in dosing metformin based on the level of kidney function from @kdigo.org #Nephpearls #NephJC #NephSky
Suggested approach in dosing metformin based on the level of kidney function from @kdigo.org #Nephpearls #NephJC #NephSky
Suggested approach in dosing metformin based on the level of kidney function from @goKDIGO #Nephpearls #NephJC
Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @kdigo.org #Nephpearls #NephJC #NephSky
Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @kdigo.org #Nephpearls #NephJC #NephSky
Treatment algorithm for selecting glucose-lowering drugs for patients with type 2 diabetes (T2D) and CKD from @goKDIGO #Nephpearls #NephJC
Holistic approach for improving outcomes in patients with diabetes and CKD from @kdigo.org #Nephpearls #NephJC #NephSky
Holistic approach for improving outcomes in patients with diabetes and CKD from @kdigo.org #Nephpearls #NephJC #NephSky
Holistic approach for improving outcomes in patients with diabetes and CKD from @goKDIGO #Nephpearls #NephJC
(ADA) Standards of Medical Care in Diabetes and the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease each provide evidence-based recommendations for management. A joint group of ADA and KDIGO
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
RT @MedInternaFAA: El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Med…
El Dr. Jonathan Chávez con la clase: “enfermedad renal relacionada a diabetes mellitus”, para nuestros residentes de Medicina Interna. • https://t.co/eJ4rMc95Nh • https://t.co/GVFP5OJtTr • https://t.co/8rAWllWGfQ https://t.co/TqvtrjNS5M
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease https://t.co/55LyqzJqp0… @goKDIGO https://t.co/T7rtgMHeyN
@Nephro_Sparks @KidneyInCVD @goKDIGO @LeslieGewin @RangaswJ @AHAScience What does the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease say about these medications? https://t.co/esttg4qffd
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022; 102(5S):S1–S127.
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence - Kidney International https://t.co/Xp73dHzmhM
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence - Kidney International✅✅✅ https://t.co/e1LVGVvsgG
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International ADAと合同で出たけど、それと同じ内容? https://t.co/MzJCHUAvUq
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @ISNkidneycare: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int.…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease #CKD. 2022 from @Kidney_Int. ➡️ https://t.co/3zrkRwdq4n #DKD https://t.co/qkhaHMAT7O
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @Leo_Santo5:
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
RT @CristobMorales: https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDI…
https://t.co/PIezB04cFx KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE @goKDIGO @jlgorriz @jorgericof @nuriaareste @sociedadSEEN @SENefrologia https://t.co/y809nGZdyI